Hepatic steatosis in chronic hepatitis C is a significant risk factor for developing hepatocellular carcinoma independent of age, sex, obesity, fibrosis stage and response to interferon therapy
スポンサーリンク
概要
- 論文の詳細を見る
- 2010-09-01
著者
-
Nakanishi Hiroyuki
Division Of Gastroenterology And Hepatology Musashino Red Cross Hospital
-
Tanaka Tomohiro
Division Of Endocrinology And Metabolism Department Of Medicine And Clinical Science Kyoto Universit
-
Kurosaki Masayuki
Department Of Gastroenterology And Hepatology Tokyo Medical And Dental University
-
ASAHINA YASUHIRO
Division of Gastroenterology and Hepatology, Musashino Red Cross Hospital
-
IZUMI NAMIKI
Division of Gastroenterology and Hepatology, Musashino Red Cross Hospital
-
KUROSAKI Masayuki
Division of Gastroenterology and Hepatology, Musashino Red Cross Hospital
-
UEDA Ken
Division of Gastroenterology and Hepatology, Musashino Red Cross Hospital
-
TSUCHIYA Kaoru
Division of Gastroenterology and Hepatology, Musashino Red Cross Hospital
-
ITAKURA Jun
Division of Gastroenterology and Hepatology, Musashino Red Cross Hospital
-
Izumi Namiki
Division Of Gastroenterology And Hepatology Musashino Red Cross Hospital
-
Kuzuya Teiji
Division Of Gastroenterology And Hepatology Musashino Red Cross Hospital
-
ENOMOTO Nobuyuki
First Department of Internal Medicine, University of Yamanashi
-
Kurosaki Masayuki
Department Of Gastroenterology And Hepatology Musashino Red-cross Hospital
-
Kurosaki Masayuki
Division Of Gastroenterology And Hepatology Musashino Red Cross Hospital
-
Tanaka Tomohiro
Division Of Gastroenterology And Hepatology Musashino Red Cross Hospital
-
Itakura Jun
Division Of Gastroenterology And Hepatology Musashino Red Cross Hospital
-
Itakura Jun
Department Of Gastroenterology And Hepatology Faculty Of Medicine Tokyo Medical And Dental Universit
-
Ueda Ken
Division Of Gastroenterology And Hepatology Musashino Red Cross Hospital
-
Takahashi Yuka
Division Of Gastroenterology And Hepatology Musashino Red Cross Hospital
-
Tsuchiya Kaoru
Division Of Gastroenterology And Hepatology Musashino Red Cross Hospital
-
HOSOKAWA Takanori
Division of Gastroenterology and Hepatology, Musashino Red Cross Hospital
-
MATSUNAGE Kotaro
Division of Pathology, Musashino Red Cross Hospital
-
HIRAYAMA Itsuko
Division of Gastroenterology and Hepatology, Musashino Red Cross Hospital
-
SATO Mitsuaki
Division of Gastroenterology and Hepatology, Musashino Red Cross Hospital
-
YASUI Yutaka
Division of Gastroenterology and Hepatology, Musashino Red Cross Hospital
-
TAMAKI Nobuharu
Division of Gastroenterology and Hepatology, Musashino Red Cross Hospital
-
ITAKURA June
Division of Gastroenterology and Hepatology, Musashino Red Cross Hospital
-
Yasui Yutaka
Division Of Gastroenterology And Hepatology Musashino Red Cross Hospital
-
Sato Mitsuaki
Division Of Gastroenterology And Hepatology Musashino Red Cross Hospital
-
Hirayama Itsuko
Division Of Gastroenterology And Hepatology Musashino Red Cross Hospital
-
Tamaki Nobuharu
Division Of Gastroenterology And Hepatology Musashino Red Cross Hospital
-
Enomoto Nobuyuki
First Department Of Internal Medicine University Of Yamanashi
-
Enomoto Nobuyuki
First Department Of Internal Medicine Faculty Of Medicine University Of Yamanashi
-
Hosokawa Takanori
Division Of Gastroenterology And Hepatology Musashino Red Cross Hospital
-
Matsunage Kotaro
Division Of Pathology Musashino Red Cross Hospital
-
Asahina Yasuhiko
Division Of Gastroenterology And Hepatology Musashino Red Cross Hospital
-
Asahina Yasuhiro
Division Of Gastroenterology And Hepatology Musashino Red Cross Hospital
関連論文
- Case-control study for the identification of virological factors associated with fulminant hepatitis B
- Guidelines for the antiviral therapy of hepatitis C virus carriers with normal serum aminotransferase based on platelet counts
- Spatial and chronological differences in hepatitis B virus genotypes from patients with acute hepatitis B in Japan
- Central melanocortin signaling and leptin resistance
- LAPAROSCOPLC RADIOFREQUENCY ABLATION FOR HEPATOCELLULAR CARCINOMA
- Repeated radiofrequency ablation for the distant recurrence in the liver in patients with chronic hepatitis C virus infection achieving long-term survival
- Serum KL-6 as a novel tumor marker for hepatocellular carcinoma in hepatitis C virus infected patients
- Prospective randomized crossover trial of combination therapy with bezafibrate and UDCA for primary biliary cirrhosis
- Enhancement of mitochondrial gene expression in the liver of primary biliary cirrhosis
- Predictive values of amino acid sequences of the core and NS5A regions in antiviral therapy for hepatitis C : a Japanese multi-center study
- Assessment of Kupffer cells by ferumoxides-enhanced MR imaging is beneficial for diagnosis of hepatocellular carcinoma : comparison of pathological diagnosis and perfusion patterns assessed by CT hepatic arteriography and CT arterioportography
- Hepatitis B virus mutations associated with lamivudine therapy in patients with chronic hepatitis B
- Hemolysis, Elevated Liver Enzymes, and Low Platelets Syndrome Associated with Primary Anti-Phospholipid Antibody Syndrome
- Hepatic steatosis in chronic hepatitis C is a significant risk factor for developing hepatocellular carcinoma independent of age, sex, obesity, fibrosis stage and response to interferon therapy
- Griseofulvin, an oral antifungal agent, suppresses hepatitis C virus replication in vitro
- -114- EFFECT OF SURGICAL PROCEDURE ON POSTOPERATIVE PULMONARY REGURGITATION IN PATIENTS WITH TETRALOGY OF FALLOT : Congenital Heart Disease, Kawasaki Disease : FREE COMMUNICATIONS(I) : PROCEEDINGS OF THE 51th ANNUAL SCIENTIFIC MEETING OF THE JAPANESE CIRC
- HEMODYNAMIC CHARACTERISTICS IN PATIENTS WITH SIMPLE TRANSPOSITION OF THE GREAT ARTERIES FOLLOWING BLALOCK-TAUSSIG SHUNT : Congenital Heart Disease : PROCEEDINGS OF THE 50th ANNUAL SCIENTIFIC MEETING OF THE JAPANESE CIRCULATION SOCIETY
- Negative regulation of intracellular hepatitis C virus replication by interferon regulatory factor 3
- Changes of HCV quasispecies during combination therapy with interferon and ribavirin
- Amino acid substitutions in PKR-eIF2 phosphorylation homology domain (PePHD) of hepatitis C virus E2 protein in genotype 2a/2b and 1b in Japan and interferon efficacy
- Two flavonoids extracts from Glycyrrhizae radix inhibit in vitro hepatitis C virus replication
- Divergent activities of interferon-alpha subtypes against intracellular hepatitis C virus replication
- A case of primary leiomyoma of the liver in a patient without evidence of immunosuppression
- Differential diagnosis of hepatic nodules using delayed parenchymal phase imaging of levovist contrast ultrasound : comparative study with SPIO-MRI
- LAPAROSCOPIC ABLATION THERAPY FOR HEPATOCELLULAR CARCINOMA. CLINICAL SIGNIFICANCE OF A NEWLY DEVELOPED LAPAROSCOPIC SECTOR ULTRASONIC PROBE
- Comparison of HCV-associated gene expression and cell signaling pathways in cells with or without HCV replicon and in replicon-cured cells
- DICKKOPF-4 and -2 genes are upregulated in human colorectal cancer
- Inhibition of hepatitis C virus replication by chloroquine targeting virus-associated autophagy
- DIAGNOSIS AND MANAGEMENT OF MYOCARDIAL INFARCTION DUE TO KAWASAKI DISEASE : Congenital Heart Disease, Kawasaki Disease : FREE COMMUNICATIONS (VI) : PROCEEDINGS OF THE 49th ANNUAL SCIENTIFIC MEETING OF THE JAPANESE CIRCULATION SOCIETY
- HEMODYNAMIC EFFECTS OF NITROPRUSSIDE IN CHILDREN WITH ISOLATED MITRAL REGURGITATION : Valvular Heart Disease, Extracorporeal Circulation : III : 48 Annual Scientific Meeting, Japanese Circulation Society
- LEFT VENTRICULAR CONTRACTILITY IN PATIENTS WITH KAWASAKI DISEASE : PROCEEDINGS OF THE 47th ANNUAL SCIENTIFIC MEETING OF THE JAPANESE CIRCULATION SOCIETY : Kawasaki Disease
- QUANTITATIVE EVALUATION OF PULMONARY REGURGITATION BY FLOW VELOCITY PROBE IN PATIENTS WITH TETRALOGY OF FALLOT UNDERCOING CORRECTIVE SURGERY : Ventricular Function : 46th Annual Scientific Meeting, Japanese Circulation Society
- Mutations in the interferon sensitivity determining region and virological response to combination therapy with pegylated-interferon alpha 2b plus ribavirin in patients with chronic hepatitis C-1b infection
- Guidelines for the treatment of chronic hepatitis and cirrhosis due to hepatitis C virus infection for the fiscal year 2008 in Japan
- Guidelines for the treatment of chronic hepatitis and cirrhosis due to hepatitis B virus infection for the fiscal year 2008 in Japan
- ASSESSMENT OF LEFT VENTRICULAR CONTRACTILITY FROM SYSTOLIC PRESSURE-DIAMETER RELATIONS IN INFANTS AND CHILDREN WITH HEART DISEASE : Ventricular function (I) : FREE COMMUNICATIONS (Abstract) : 45 Annual Scientific Meeting, Japanese Circulation Society
- CLINICAL EVALUATION OF RIGHT VENTRICULAR DIASTOLIC FILLING BY PHASIC TRICUSPID FLOW VELOCITY : Doppler, Computed Tomography : PROCEEDINGS OF THE 44th ANNUAL SCIENTIFIC MEETING OF THE JAPANESE CIRCULATION SOCIETY
- A predictive model of response to peginterferon ribavirin in chronic hepatitis C using classification and regression tree analysis
- Clinical aspects of congenital cystic dilatation of the common bile duct in adults
- Prolonged treatment with pegylated interferon α 2b plus ribavirin improves sustained virological response in chronic hepatitis C genotype 1 patients with late response in a clinical real-life setting in Japan
- Epithelial cell proliferation activity of the biliary ductal system with congenital biliary malformations
- ITPA gene variant protects against anemia induced by pegylated interferon-α and ribavirin therapy for Japanese patients with chronic hepatitis C
- Optimal timing of interferon treatment for acute hepatitis C
- Accumulation of refractory factors for pegylated interferon plus ribavirin therapy in older female patients with chronic hepatitis C
- Factors predictive of sustained virological response following 72 weeks of combination therapy for genotype 1b hepatitis C
- How to improve virological sustained response rate by interferon therapy for patients with chronic hepatitis C
- Pretreatment prediction of response to peginterferon plus ribavirin therapy in genotype 1 chronic hepatitis C using data mining analysis
- Viral factors influencing the response to the combination therapy of peginterferon plus ribavirin in chronic hepatitis C
- Pretreatment prediction of anemia progression by pegylated interferon alpha-2b plus ribavirin combination therapy in chronic hepatitis C infection : decision-tree analysis
- Genetic changes in the interferon sensitivity-determining region of hepatitis C virus (HCV) during the natural course of infection : an implication for the gene function in the role of chronic infection
- Magnetic Resonance Elastography for Staging Liver Fibrosis in Chronic Hepatitis C
- MR-based Measurements of Portal Vein Flow and Liver Stiffness for Predicting Gastroesophageal Varices
- Cancer preventive effect of pegylatecl interferon α-2b plus ribavirin in a real-life clinical setting in Japan : PERFECT interim analysis
- Magnetic Resonance Elastography for Staging Liver Fibrosis in Chronic Hepatitis C
- Aberrant expression of tumor suppressors CADM1 and 4.1B in invasive lesions of primary breast cancer
- Serum HBV RNA as a possible marker of HBV replication in the liver during nucleot(s)ide analogue therapy
- Clinical effectiveness of bipolar radiofrequency ablation for small liver cancers